104 related articles for article (PubMed ID: 37258396)
1. Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race.
Li S; Suehs BT; Fu A; Sangaré L; Kim C; Gastanaga VM; Liu J; Yan H; Xu Y; Mikhael J
Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):616-625. PubMed ID: 37258396
[TBL] [Abstract][Full Text] [Related]
2. Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis.
Bishnoi R; Xie Z; Shah C; Bian J; Murthy HS; Wingard JR; Farhadfar N
Cancer Med; 2021 Jan; 10(1):70-78. PubMed ID: 33169938
[TBL] [Abstract][Full Text] [Related]
3. Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database.
Fakhri B; Fiala MA; Shah N; Vij R; Wildes TM
Cancer; 2020 Feb; 126(4):808-813. PubMed ID: 31721140
[TBL] [Abstract][Full Text] [Related]
4. Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia: An Analysis of Within- and Between-Hospital Variation.
Downing NS; Wang C; Gupta A; Wang Y; Nuti SV; Ross JS; Bernheim SM; Lin Z; Normand ST; Krumholz HM
JAMA Netw Open; 2018 Sep; 1(5):e182044. PubMed ID: 30646146
[TBL] [Abstract][Full Text] [Related]
5. Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.
Moreau P; Mateos MV; Berenson JR; Weisel K; Lazzaro A; Song K; Dimopoulos MA; Huang M; Zahlten-Kumeli A; Stewart AK
Lancet Oncol; 2018 Jul; 19(7):953-964. PubMed ID: 29866475
[TBL] [Abstract][Full Text] [Related]
6. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure.
Rathore SS; Foody JM; Wang Y; Smith GL; Herrin J; Masoudi FA; Wolfe P; Havranek EP; Ordin DL; Krumholz HM
JAMA; 2003 May; 289(19):2517-24. PubMed ID: 12759323
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
[TBL] [Abstract][Full Text] [Related]
8. Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial.
Dimopoulos MA; Goldschmidt H; Niesvizky R; Joshua D; Chng WJ; Oriol A; Orlowski RZ; Ludwig H; Facon T; Hajek R; Weisel K; Hungria V; Minuk L; Feng S; Zahlten-Kumeli A; Kimball AS; Moreau P
Lancet Oncol; 2017 Oct; 18(10):1327-1337. PubMed ID: 28843768
[TBL] [Abstract][Full Text] [Related]
9. Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study.
Colantonio LD; Saag KG; Singh JA; Chen L; Reynolds RJ; Gaffo A; Plante TB; Curtis JR; Bridges SL; Levitan EB; Chaudhary NS; Howard G; Safford MM; Muntner P; Irvin MR
Arthritis Res Ther; 2020 Apr; 22(1):86. PubMed ID: 32299504
[TBL] [Abstract][Full Text] [Related]
10. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population.
Croft JB; Giles WH; Pollard RA; Keenan NL; Casper ML; Anda RF
Arch Intern Med; 1999 Mar; 159(5):505-10. PubMed ID: 10074960
[TBL] [Abstract][Full Text] [Related]
11. Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries.
Mentias A; Desai MY; Vaughan-Sarrazin MS; Rao S; Morris AA; Hall JL; Menon V; Hockenberry J; Sims M; Fonarow GC; Girotra S; Pandey A
Circulation; 2022 Jan; 145(2):110-121. PubMed ID: 34743555
[TBL] [Abstract][Full Text] [Related]
12. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Mina R; Musto P; Rota-Scalabrini D; Paris L; Gamberi B; Palmas A; Aquino S; de Fabritiis P; Giuliani N; De Rosa L; Gozzetti A; Cellini C; Bertamini L; Capra A; Oddolo D; Vincelli ID; Ronconi S; Pavone V; Pescosta N; Cea M; Fioritoni F; Ballanti S; Grasso M; Zamagni E; Belotti A; Boccadoro M; Gay F
Lancet Oncol; 2023 Jan; 24(1):64-76. PubMed ID: 36528035
[TBL] [Abstract][Full Text] [Related]
13. Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction.
Ziaeian B; Heidenreich PA; Xu H; DeVore AD; Matsouaka RA; Hernandez AF; Bhatt DL; Yancy CW; Fonarow GC
JACC Heart Fail; 2017 Jul; 5(7):483-493. PubMed ID: 28501527
[TBL] [Abstract][Full Text] [Related]
14. Thirty-day readmission rates for Medicare beneficiaries by race and site of care.
Joynt KE; Orav EJ; Jha AK
JAMA; 2011 Feb; 305(7):675-81. PubMed ID: 21325183
[TBL] [Abstract][Full Text] [Related]
15. Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial.
Yong K; Wilson W; de Tute RM; Camilleri M; Ramasamy K; Streetly M; Sive J; Bygrave CA; Benjamin R; Chapman M; Chavda SJ; Phillips EH; Del Mar Cuadrado M; Pang G; Jenner R; Dadaga T; Kamora S; Cavenagh J; Clifton-Hadley L; Owen RG; Popat R
Lancet Haematol; 2023 Feb; 10(2):e93-e106. PubMed ID: 36529145
[TBL] [Abstract][Full Text] [Related]
16. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.
Chen J; Normand SL; Wang Y; Krumholz HM
JAMA; 2011 Oct; 306(15):1669-78. PubMed ID: 22009099
[TBL] [Abstract][Full Text] [Related]
17. Association Between Medicare Expenditures and Adverse Events for Patients With Acute Myocardial Infarction, Heart Failure, or Pneumonia in the United States.
Wang Y; Eldridge N; Metersky ML; Sonnenfeld N; Rodrick D; Fine JM; Eckenrode S; Galusha DH; Tasimi A; Hunt DR; Bernheim SM; Normand ST; Krumholz HM
JAMA Netw Open; 2020 Apr; 3(4):e202142. PubMed ID: 32259263
[TBL] [Abstract][Full Text] [Related]
18. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.
Abraham J; Bharmi R; Jonsson O; Oliveira GH; Artis A; Valika A; Capodilupo R; Adamson PB; Roberts G; Dalal N; Desai AS; Benza RL
JAMA Cardiol; 2019 Jun; 4(6):556-563. PubMed ID: 31090869
[TBL] [Abstract][Full Text] [Related]
19. Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program.
Huckfeldt P; Escarce J; Sood N; Yang Z; Popescu I; Nuckols T
JAMA Netw Open; 2019 Mar; 2(3):e190634. PubMed ID: 30874780
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
